MSH proteins are capable of recognizing damage in DNA due to a common chemotheraputic, cisplatin, and consequently participate in the initiation of cell death pathways. While previous studies have used computational modeling and cell biology to demonstrate that there are specific structural responses to cisplatin damage that are critical to the initiation of apoptosis, this study demonstrates that there are also specific dynamical changes that are also associated with cisplatin binding. These changes further distinguish the undamaged MutS/DNA complex from the damaged MutS/DNA complex and suggest that there are dynamical aspects to the response of MSH proteins to the binding of DNA damaged by therapeutics; consideration of these responses may influence further drug design and development.
Keywords: MutS, molecular dynamics, cisplatin, DNA repair
Rights & PermissionsPrintExport